The Cardiology Advisor

Automated Insulin Delivery Benefits T2D Regardless of C-Peptide Levels

Automated insulin delivery was improved with improved glycemic control metrics among patients with type 2 diabetes regardless of C-peptide levels.
Medscape

AID Systems Help T2D Patients Regardless of C-Peptide Levels

Adults with insulin-treated type 2 diabetes benefit from automated insulin delivery systems regardless of their C-peptide levels, a recent study shows.
Medical Dialogues

Automated Insulin Delivery Benefits Adults with Type 2 Diabetes Regardless of C-Peptide Levels: Study Finds

USA: A new study published in Diabetes Care revealed that automated insulin delivery (AID) systems lowered A1C levels and ...
Morningstar

Tandem Diabetes Care Announces Publication Showing Adults With Type 2 Diabetes Benefit from Automated Insulin Delivery Regardless of C-Peptide Levels

Tandem Diabetes Care Announces Publication Showing Adults With Type 2 Diabetes Benefit from Automated Insulin Delivery Regardless of C-Peptide Levels This sub-analysis is the first study to evaluate ...
Medscape

Consensus Report: Management of Type 1 Diabetes in Adults

A new consensus report on the management of type 1 diabetes in adults was presented recently at the European Association for ...
Healio

Verapamil effect uncertain on C-peptide levels in new-onset type 1 diabetes

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Adults with new-onset type 1 diabetes receiving ...
Seeking Alpha

Tandem Diabetes Care Announces Publication Showing Adults With Type 2 Diabetes Benefit from Automated Insulin Delivery Regardless of C-Peptide Levels

This sub-analysis is the first study to evaluate AID outcomes for people with type 2 diabetes using the Center for Medicare and Medicaid Services (CMS) criteria for insulin pump coverage. SAN ...